Investigators from US Oncology Research, the US Oncology Network and Ontada Present Data Highlighting Key Advances and Insights at the 2022 American Society of Clinical Oncology Annual Meeting
At ASCO 2022, over 80 studies on cancer, value-based care, and health tech will be presented, including 10 oral sessions.
During the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, principal investigators from US Oncology Research, The US Oncology Network and Ontada will present detailed results from more than 80 studies. Presentations include 10 oral sessions on topics including lung and ovarian cancers, as well as research involving value-based care and the use of health technologies. An oral presentation evaluating health technologies and their impact on quality of care and health disparities was co-authored by Debra Patt, M.D., Ph.D., MBA, Executive Vice President, Public Policy, Payer Relations, and Strategic Initiatives at Texas Oncology, and will be presented on Monday, June 6 at 5:12 p.m.
Click here to read the full article.
Click here to read the full article.